Pharma Integrates 2023 – On Demand Videos – Track 2

[et_pb_section fb_built=”1″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_row column_structure=”1_3,1_3,1_3″ use_custom_gutter=”on” gutter_width=”2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_button button_url=”https://lifescienceintegrates.com/pharma-integrates-2023-on-demand-videos-track-1/” button_text=”See Track one” _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”][/et_pb_button][/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][/et_pb_column][/et_pb_row][et_pb_row _builder_version=”4.16″ _module_preset=”default” background_color=”#ffffff” custom_padding=”20px||||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.19.4″ _module_preset=”default” header_text_color=”#0092A9″ global_colors_info=”{}”]

Pharma Integrates 2023 Track 2

[/et_pb_text][et_pb_divider _builder_version=”4.16″ _module_preset=”008f89d7-23fe-4a6f-8475-d842169ec4d7″ global_colors_info=”{}”][/et_pb_divider][et_pb_divider _builder_version=”4.16″ _module_preset=”008f89d7-23fe-4a6f-8475-d842169ec4d7″ global_colors_info=”{}”][/et_pb_divider][/et_pb_column][/et_pb_row][et_pb_row column_structure=”1_3,2_3″ use_custom_gutter=”on” gutter_width=”1″ make_equal=”on” _builder_version=”4.19.4″ _module_preset=”default” background_enable_color=”off” width=”100%” module_alignment=”center” custom_margin=”12px||12px||false|false” custom_padding=”0px|1%|0px|1%|false|false” global_colors_info=”{}”][et_pb_column type=”1_3″ _builder_version=”4.19.4″ _module_preset=”default” background_enable_color=”off” background_image=”https://lifescienceintegrates.com/wp-content/uploads/2020/07/400×300-Pharma-Track-2.jpg” custom_padding=”10%||9%||false|false” border_color_all=”#909092″ global_colors_info=”{}”][/et_pb_column][et_pb_column type=”2_3″ _builder_version=”4.16″ _module_preset=”default” custom_padding=”0px|0px|0px|0px|false|false” border_width_all=”1px” border_color_all=”#e9e9e9″ global_colors_info=”{}”][et_pb_text _builder_version=”4.19.4″ _module_preset=”default” header_3_text_align=”center” header_3_font_size=”26px” header_3_letter_spacing=”1px” header_3_line_height=”1.2em” custom_padding=”5%|5%|5%|5%|false|false” global_colors_info=”{}”]

Big Health Issues and Enablers

How do we tackle some of the biggest health challenges, such as chronic conditions, respiratory and cancer?

How do we enable a better Industry, through creating diverse skilled teams, empowering the patient and navigating the economic and regulatory environment?

[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row _builder_version=”4.16″ _module_preset=”default” custom_padding=”0px||||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text admin_label=”Opening Remarks and Fireside 1″ _builder_version=”4.19.4″ _module_preset=”default” custom_padding=”20px||||false|false” global_colors_info=”{}”]

Welcome and Fireside Chat

[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_video src=”https://vimeo.com/885377828?share=copy” _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”][/et_pb_video][/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”]

Welcome & Opening Remarks

Susan Rienow | Country President UK, Pfizer | President, ABPI

Introduced by:

Trevor Jones CBE | Chairman, e-Therapeutics | Board Member, Respiratory Innovation Wales and Ascension Healthcare

[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_video src=”https://vimeo.com/885379205?share=copy” _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”][/et_pb_video][/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”]

Fireside Chat

Pharma CEO Plenary Discussion: View from the top – navigating the opportunities and challenges presented by a dynamic UK environment and achieving success.

Speakers include:

Susan Rienow | Country President UK, Pfizer | President, ABPI

Marie-Andrée Gamache | Country President | Novartis UK and Ireland

Dr Antonio Payano | Chief Executive Officer | Bayer UK & Ireland

Interviewed by:

Tamsin Berry | Head of Policy and Partnerships, AreteiaTx | Partner, Population Health Partners

[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row _builder_version=”4.16″ _module_preset=”default” custom_padding=”50px||||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_divider _builder_version=”4.16″ _module_preset=”008f89d7-23fe-4a6f-8475-d842169ec4d7″ custom_padding=”0px||20px||false|false” global_colors_info=”{}”][/et_pb_divider][et_pb_text admin_label=”Session 1″ _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”]

Session 1: Panel Discussion followed by Q&A

[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_video src=”https://vimeo.com/886116588?share=copy” module_id=”#maths” _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”][/et_pb_video][et_pb_video src=”https://vimeo.com/886116367?share=copy” module_id=”#maths” _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”][/et_pb_video][/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”]

Have a little ‘patients’

The patient voice is getting louder in all aspects of healthcare, from self-diagnosis to policy discussion and clinical trial design. What more can be done to engage patient groups and put patients at the centre of their healthcare journey?

FACILITATED BY

Kathryn Simpson | Business Consultant | Kathryn Simpson Consulting Limited

PANELLISTS

Charlotte Harris | Head of Front End Innovation | Team Consulting

Oleksandr Gorbenko | Global Patient Affairs Director | Ipsen

Catherine Kettleborough | Translational Challenge Leader | LifeArc

Abigail Epstein | Head of Communications and Patient Advocacy | Takeda

[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row _builder_version=”4.16″ _module_preset=”default” custom_padding=”50px||||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_divider _builder_version=”4.16″ _module_preset=”008f89d7-23fe-4a6f-8475-d842169ec4d7″ custom_padding=”0px||20px||false|false” global_colors_info=”{}”][/et_pb_divider][et_pb_text admin_label=”Session 2″ _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”]

Session 2: Panel Discussion followed by Q&A

[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_video src=”https://vimeo.com/886118173?share=copy” module_id=”#standard” _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”][/et_pb_video][et_pb_video src=”https://vimeo.com/886117669?share=copy” module_id=”#standard” _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”][/et_pb_video][/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”]

Britain’s got talent?

As our ability to treat diseases becomes ever more advanced, the skills gap across the pharmaceutical sector continues to grow. How can we upskill our workforce, better manage talent, and encourage diversity to drive innovation?

FACILITATED BY

Jane Kennedy | Chief Business Officer | Discovery Park

PANELLISTS

Fiona Marston | Chair & Chief Executive Officer | Erebagen

Nick Smith | Regional Operations Manager | Scitech

Amina Udechuku | Head of Vaccines, UK | Takeda UK

Andrew Croydon | Director, Education and Examination Policy & Partnerships | The ABPI

[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row _builder_version=”4.16″ _module_preset=”default” custom_padding=”50px||||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_divider _builder_version=”4.16″ _module_preset=”008f89d7-23fe-4a6f-8475-d842169ec4d7″ custom_padding=”0px||20px||false|false” global_colors_info=”{}”][/et_pb_divider][et_pb_text admin_label=”Session 3″ _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”]

Session 3: Panel Discussion followed by Q&A

 

[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_video src=”https://vimeo.com/886119511?share=copy” module_id=”#supply” _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”][/et_pb_video][et_pb_video src=”https://vimeo.com/886118975?share=copy” module_id=”#supply” _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”][/et_pb_video][/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”]

From ‘sick care’ to ‘health care’

With NHS demand outstripping capacity, we must focus on preventative healthcare. How can we turn a ‘sick care’ service into a ‘health care’ service that supports a healthier and wealthier nation?

FACILITATED BY

John Deanfield CBE | Professor of Cardiology | University College London

PANELLISTS

Marcel Gehrung | Chief Executive Officer and Co-Founder | Cyted

Cedi Frederick | Chair | NHS Kent and Medway

Tamsin Berry | Partner & Head of Policy and Partnerships | AreteiaTx & Population Health Partners

Sir Keith Mills GBE DL | Chairman | Camelot

[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row _builder_version=”4.16″ _module_preset=”default” custom_padding=”50px||||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_divider _builder_version=”4.16″ _module_preset=”008f89d7-23fe-4a6f-8475-d842169ec4d7″ custom_padding=”0px||20px||false|false” global_colors_info=”{}”][/et_pb_divider][et_pb_text admin_label=”Session 4″ _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”]

Session 4: Panel Discussion followed by Q&A

 

[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_video src=”https://vimeo.com/886121031?share=copy” module_id=”#fire2″ _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”][/et_pb_video][et_pb_video src=”https://vimeo.com/886120348?share=copy” module_id=”#fire2″ _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”][/et_pb_video][/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”]

Trialling a new approach to clinical trials

Adaptive trials, decentralised trials, virtual trials … many new clinical trials models are appearing on the scene. How can the UK deliver more innovative trials across the board to make the most of assets within the NHS?

FACILITATED BY

Lord James O’Shaughnessy | Senior Partner | Newmarket Strategy

PANELLISTS

James Chennells | Head Exploration & Discovery R&D Data Science & Artificial Intelligence | Bayer

Paul Wicks | Independent Consultant | Wicks Digital Health

Miranda Mapleton | Chief Executive Officer | White Swan

Nina Skorytchenko | Co-founder & Chief Executive Officer | Avenna

[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row _builder_version=”4.16″ _module_preset=”default” custom_padding=”50px||||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_divider _builder_version=”4.16″ _module_preset=”008f89d7-23fe-4a6f-8475-d842169ec4d7″ custom_padding=”0px||20px||false|false” global_colors_info=”{}”][/et_pb_divider][et_pb_text admin_label=”Session 5″ _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”]

Session 5: Panel Discussion followed by Q&A

 

[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_video src=”https://vimeo.com/886115219?share=copy” module_id=”#fire2″ _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”][/et_pb_video][et_pb_video src=”https://vimeo.com/886121871?share=copy” module_id=”#fire2″ _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”][/et_pb_video][/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”]

But does it sell?

Regulatory and commercialisation strategies can make or break the success of new treatments. How can we streamline processes to accelerate market access and deliver ‘value’?

FACILITATED BY

Martino Picardo | Chairman | Discovery Park

PANELLISTS

Suzanne Dilly | Chief Executive Officer | ValiRx PLC

Camilla Easter | Chief Executive Officer | Oxford Medical Products

Hilary Mills-Baker | European Quality and Validation Manager | Emerson

Andrew Webb | Chief Executive Officer | Extruded Pharmaceuticals

[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row _builder_version=”4.16″ _module_preset=”default” custom_padding=”50px||||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_divider _builder_version=”4.16″ _module_preset=”008f89d7-23fe-4a6f-8475-d842169ec4d7″ custom_padding=”0px||20px||false|false” global_colors_info=”{}”][/et_pb_divider][/et_pb_column][/et_pb_row][et_pb_row column_structure=”1_3,1_3,1_3″ use_custom_gutter=”on” gutter_width=”2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_button button_url=”https://lifescienceintegrates.com/pharma-integrates-2023-on-demand-videos-track-1/” button_text=”See Track one” _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”][/et_pb_button][/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][/et_pb_column][/et_pb_row][/et_pb_section]